The Hindu·3 min read·medium
Finerenone helps slow kidney disease in patients without diabetes
A
Anirban Mukhopadhyay
✦AI Summary
New global studies indicate that the drug finerenone can effectively slow the progression of chronic kidney disease in patients who do not have diabetes. By blocking inflammation and scarring, the medication offers a new treatment pathway for those at risk of kidney failure.
In chronic kidney disease , the kidneys gradually lose their ability to filter waste from the blood. While diabetes is one of its leading causes, many patients develop the condition because of high blood pressure, autoimmune disorders or other conditions that damage the kidney’s filtering units.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in